Discover
COLL
Collegium Pharmaceutical, Inc.
35.87
2 x 26.18
2 x 46.77
bid
ask
-
0.33
0.91%
2 @ 04:00 PM
35.87 +0.00 (0.00%)
| Ytd | -22.53% | |
| 1y | 18.38% |
35.74
day range
37.22
29.19
52 week range
50.79
| Open | 36.55 | Prev Close | 36.20 | Low | 35.74 | High | 37.22 | Mkt Cap | 1.16B |
| Vol | 397.97K | Avg Vol | 462.52K | EPS | 2.06 | P/E | 17.41 | Forward P/E | 4.76 |
| Beta | 0.75 | Short Ratio | 14.46 | Inst. Own | 127.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 34.23 | 200-d Avg | 39.19 | 1yr Est | 54.33 |
| Income Statement | |||
| Total Revenue | 193.52M | ||
| Revenues (USD) | 193.52M | ||
| Cost of Revenue | 76.27M | ||
| Gross Profit | 117.25M | ||
| Operating Expenses | 86.35M | ||
| Selling, General and Administrative Expense | 86.35M | ||
| Operating Income | 30.90M | ||
| Interest Expense | 15.86M | ||
| Income Tax Expense | 4.24M | ||
| Net Income | 14.50M | ||
| Net Income Common Stock | 14.50M | ||
| Net Income Common Stock (USD) | 14.50M | ||
| Consolidated Income | 14.50M | ||
| Earnings per Basic Share | 0.45 | ||
| Earnings per Basic Share (USD) | 0.45 | ||
| Earnings per Diluted Share | 0.40 | ||
| Earning Before Interest & Taxes (EBIT) | 34.60M | ||
| Earning Before Interest & Taxes (USD) | 34.60M | ||
| Weighted Average Shares | 32.09M | ||
| Weighted Average Shares Diluted | 40.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 289.56M | ||
| Cash and Equivalents (USD) | 289.56M | ||
| Investments | 153.10M | ||
| Investments Current | 153.10M | ||
| Trade and Non-Trade Receivables | 228.76M | ||
| Current Assets | 745.67M | ||
| Property, Plant & Equipment Net | 15.64M | ||
| Total Assets | 1.65B | ||
| Debt Current | 34.07M | ||
| Total Debt | 808.06M | ||
| Current Liabilities | 434.97M | ||
| Debt Non-Current | 773.98M | ||
| Total Liabilities | 1.34B | ||
| Accumulated Retained Earnings (Deficit) | -86.63M | ||
| Accumulated Other Comprehensive Income | -219.00K | ||
| Shareholders Equity | 312.42M | ||
| Shareholders Equity (USD) | 312.42M | ||
| Assets Non-Current | 906.29M | ||
| Total Debt (USD) | 808.06M | ||
| Deferred Revenue | 9.61M | ||
| Goodwill and Intangible Assets | 759.96M | ||
| Inventory | 42.74M | ||
| Liabilities Non-Current | 904.56M | ||
| Trade and Non-Trade Payables | 6.83M | ||
| Tax Assets | 113.57M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 463.00K | ||
| Net Cash Flow from Financing | -21.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 37.40M | ||
| Capital Expenditure | -270.00K | ||
| Issuance (Purchase) of Equity Shares | 1.34M | ||
| Issuance (Repayment) of Debt Securities | -7.25M | ||
| Net Cash Flow from Investing | 1.63M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.90M | ||
| Net Cash Flow from Operations | 57.11M | ||
| Share Based Compensation | 10.88M | ||